Nalaganje...
Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia
BACKGROUND: Imatinib is a highly effective treatment for chronic myeloid leukemia (CML) that was approved by the Food and Drug Administration in 2001, and thereafter rapidly became front line therapy. This study characterized the prevailing chronic myeloid leukemia therapies in the United States and...
Shranjeno v:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2913144/ https://ncbi.nlm.nih.gov/pubmed/20670732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2010.03.018 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|